RCUS

19.83

2.56% -0.52

Handel nachbörslich: 19.83

Arcus Biosciences Inc (RCUS)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt RCUS? Forum Prognose

Schlusskurs vom Vortag:

$20.35

Offen:

$19.7

24-Stunden-Volumen:

2.36M

Relative Volume:

2.02

Marktkapitalisierung:

$2.11B

Einnahmen:

$247.00M

Nettoeinkommen (Verlust:

$-249.00M

KGV:

-6.4175

EPS:

-3.09

Netto-Cashflow:

$-267.00M

1W Leistung:

-0.25%

1M Leistung:

+48.54%

6M Leistung:

+117.43%

1J Leistung:

+27.44%

1-Tages-Spanne:

$19.69

$20.54

1-Wochen-Bereich:

$18.32

$22.11

52-Wochen-Spanne:

$6.50

$22.11

Arcus Biosciences Inc Stock (RCUS) Company Profile

Firmenname

Arcus Biosciences Inc

Sektor

Healthcare (1135)

Branche

Biotechnology (635)

Telefon

(510) 694-6200

Adresse

3928 POINT EDEN WAY, HAYWARD, CA

Mitarbeiter

674

Twitter

@arcusbio

Nächster Verdiensttermin

2024-12-06

Neueste SEC-Einreichungen

RCUS's Discussions on Twitter

Vergleichen Sie RCUS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RCUS Arcus Biosciences Inc	19.83	2.20B	247.00M	-249.00M	-267.00M	-3.09
VRTX Vertex Pharmaceuticals Inc	421.67	109.22B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	628.00	67.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	423.47	57.35B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	831.48	50.87B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	182.77	39.72B	447.02M	-1.18B	-868.57M	-6.1812

Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-26	Hochstufung	H.C. Wainwright	Neutral → Buy
2024-10-21	Eingeleitet	H.C. Wainwright	Neutral
2024-10-08	Eingeleitet	Wells Fargo	Overweight
2022-11-18	Eingeleitet	BofA Securities	Neutral
2022-10-11	Eingeleitet	Morgan Stanley	Overweight
2021-10-15	Fortgesetzt	BTIG Research	Buy
2020-11-24	Eingeleitet	Berenberg	Buy
2020-11-23	Eingeleitet	Evercore ISI	Outperform
2020-04-03	Eingeleitet	Cantor Fitzgerald	Overweight
2020-03-04	Eingeleitet	Barclays	Overweight
2019-11-12	Eingeleitet	SunTrust	Buy
2019-09-27	Eingeleitet	Mizuho	Buy
2019-05-24	Fortgesetzt	Citigroup	Buy
2018-10-09	Eingeleitet	Wedbush	Outperform
2018-04-09	Eingeleitet	Citigroup	Buy
2018-04-09	Eingeleitet	Goldman	Neutral
2018-04-09	Eingeleitet	Leerink Partners	Outperform

Alle ansehen

Arcus Biosciences Inc Aktie (RCUS) Neueste Nachrichten

12:36 PM

Arcus Biosciences Completes Successful Stock Offering - MSN

12:36 PM

05:00 AM

Does Arcus Biosciences Inc. show high probability of rebound2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com

05:00 AM

04:42 AM

How Arcus Biosciences Inc. stock reacts to job market data2025 Market Outlook & Weekly High Momentum Picks - newser.com

04:42 AM

Nov 03, 2025

Latham & Watkins Advises Arcus Biosciences in US$250 Million Public Offering of Common Stock - Legal Desire Media and Insights

Nov 03, 2025

Arcus Biosciences Completes Public Offering of Common Stock - TradingView

Nov 03, 2025

Is Arcus Biosciences Inc. stock a buy on dipsJuly 2025 Decliners & Daily Stock Trend Reports - newser.com

Nov 03, 2025

Automated trading signals detected on Arcus Biosciences Inc.Trade Volume Report & Consistent Profit Focused Trading Strategies - newser.com

Nov 03, 2025

Mizuho Raises Price Target on Arcus Biosciences to $47 From $45, Keeps Outperform Rating - MarketScreener

Nov 03, 2025

Why Arcus Biosciences Inc. stock is rated strong buyTrade Exit Summary & Verified Stock Trade Ideas - newser.com

Nov 03, 2025

What is the fair value estimate for Arcus Biosciences Inc. stock in 2025Trade Analysis Report & Expert-Curated Trade Recommendations - newser.com

Nov 03, 2025

Visual analytics tools that track Arcus Biosciences Inc. performanceBuy Signal & Weekly Breakout Watchlists - newser.com

Nov 03, 2025